M&A | Partnerships

April 25, 2022

ORHub Acquires PUR Biologics

ORHub Acquires PUR Biologics
ORHub will enter the medical device market with biologics to regenerate cartilage and address degenerative disc disease and osteoarthritis.
April 5, 2022

TheraCell Acquired by Isto Biologics

TheraCell Acquired by Isto Biologics
The move will expand Isto's portfolio of procedure-specific allografts for spine, orthopedic and sports medicine applications.
March 21, 2022

curasan Enters Joint Venture to Research Biosurgical Therapies

curasan Enters Joint Venture to Research Biosurgical Therapies
curasan and Xlife Sciences formed Novaxomx to focus on development and marketing of therapies to treat musculoskeletal diseases and tissue regeneration.
March 7, 2022

Bone Biologics Partners with MTF to Supply DBM

Bone Biologics Partners with MTF to Supply DBM
Bone Biologics' rhNELL-1 bone graft substitute product will be supplied by MTF Biologics for the initiation and improvement of bone formation.
January 26, 2022

Seikagaku Establishes New Company in Canada

Seikagaku Establishes New Company in Canada
The new company will manage a portion of Seikagaku's pharmaceutical and medical device development in North America.